Covaxin trials on 2-18 age group get a nod
The Drugs Controller General of India has granted permission to Bharat Biotech to conduct clinical trials of Covaxin on children in the 2-18 age group, according to an official release. Bharat Biotech had submitted the proposal of conducting trials on children earlier this year. An expert committee that looked into the matter asked Bharat Biotech […]
Continue Reading